APA (7th ed.) Citation

Zeng, X., Xu, W., Tong, J., Liu, J., Zhang, Z., Liu, M., . . . Yan, H. (2022). SPAG5 as a novel biomarker and potential therapeutic target via regulating AKT pathway in multiple myeloma. Leukemia & Lymphoma, 63(11), 2565. https://doi.org/10.1080/10428194.2022.2086247

Chicago Style (17th ed.) Citation

Zeng, Xinyi, et al. "SPAG5 as a Novel Biomarker and Potential Therapeutic Target via Regulating AKT Pathway in Multiple Myeloma." Leukemia & Lymphoma 63, no. 11 (2022): 2565. https://doi.org/10.1080/10428194.2022.2086247.

MLA (9th ed.) Citation

Zeng, Xinyi, et al. "SPAG5 as a Novel Biomarker and Potential Therapeutic Target via Regulating AKT Pathway in Multiple Myeloma." Leukemia & Lymphoma, vol. 63, no. 11, 2022, p. 2565, https://doi.org/10.1080/10428194.2022.2086247.